Anesthesia

Oncology·MeSH: Agnosia

15 drugs in development·12 companies·3 clinical trials

Drug Pipeline by Phase

Approved(15)

Drug	Company
bupivacaine	Spero Therapeutics, Inc. (SPRO)
emerphed	NEXUS BIOPHARMA INC (NEXS)
glycopyrrolate	Amneal Pharmaceuticals, Inc. (AMRX)
iheezo	HARROW, INC. (IMMY)
isoproterenol	NEXUS BIOPHARMA INC (NEXS)
lidocaine	CHINA PHARMA HOLDINGS, INC. (CPHI)
lidocaine	MANNKIND CORP (MNKD)
lidocaine	ANTHERA PHARMACEUTICALS INC (ANTH)
lidocaine	LUMOS PHARMA, INC. (NLNK)
lidocaine	NVN Liquidation, Inc. (NOVN)
lidocaine	AlphaTON Capital Corp (ATON)
lidocaine	SUNSET ISLAND GROUP (SUN)
norepinephrine bi	Amneal Pharmaceuticals, Inc. (AMRX)
succinylcholine	NEXUS BIOPHARMA INC (NEXS)
ursodiol	Optec International, Inc. (GM)

BioSniper tracks 15 drugs in development for Anesthesia across 12 companies.

There are 3 clinical trials targeting Anesthesia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.